Jan. 21 at 8:35 AM
The epcam data doesn't come out until at least May-June, even considering scan and readout times. The company may be delisted on Feb. 2 because it doesn't meet the minimum bidding requirements, or it may go bankrupt because it doesn't have the cash to run right away. There's no guarantee that the results are good because they weren't very satisfactory in the last scan. Scalability also seems to fall apart other than colorectal cancer. Beware of @biotechvalue instigating a buy with epcam data. He's a pump & dump. He's a vicious person who sells, telling investors to buy stocks.
$BCAB He's done that many times before.
$JSPR $ARCV